Synopsys (SNPS) Cash & Equivalents (2009 - 2026)

Synopsys (SNPS) has reported Cash & Equivalents for 18 consecutive years, with $43.1 million the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $43.1 million, down 98.82% year-over-year; the trailing twelve-month figure through Jan 2026 was $43.1 million (down 98.82% YoY), and the FY2025 annual result was $2.9 billion, down 25.92% from the prior year.
• Cash & Equivalents was $43.1 million for Q1 2026 at Synopsys, down from $2.9 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $14.1 billion in Q2 2025 and troughed at $43.1 million in Q1 2026.
• A 5-year average of $2.5 billion and a median of $1.6 billion in 2022 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2025 — Cash & Equivalents jumped 838.02% — and 2026, when it tumbled 98.82%.
• Year by year, Cash & Equivalents stood at $1.4 billion in 2022, then advanced by 11.67% to $1.6 billion in 2023, then soared by 145.88% to $3.9 billion in 2024, then dropped by 25.92% to $2.9 billion in 2025, then slumped by 98.51% to $43.1 million in 2026.
• Per Business Quant, the three latest SNPS Cash & Equivalents figures stand at $43.1 million (Q1 2026), $2.9 billion (Q4 2025), and $2.6 billion (Q3 2025).